UK renal registry 15th annual report: Chapter 6 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2011: National and centre-specific analyses

Nephron - Clinical Practice

Volumn 123, Issue SUPPL. 1, 2013, Pages 125-150

  Rao, Anirudh ^a   Gilg, Julie ^a   Williams, Andrew ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Chronic kidney disease; Dialysis; End stage renal disease; Epidemiology; Erythropoietin; Erythropoietin stimulating agent; European Best Practice Guidelines; Ferritin; Haemodialysis; Haemoglobin; NICE; Peritoneal dialysis; Renal Association

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; DIALYSIS; DISEASE REGISTRY; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UNITED KINGDOM; ADULT; FEMALE; HEMODIALYSIS PATIENT; MALE; SYSTEMIC DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANNUAL REPORTS AS TOPIC; BIOLOGICAL MARKERS; ERYTHROPOIETIN; FEMALE; FERRITINS; GREAT BRITAIN; HEALTH SURVEYS; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROLOGY; PREVALENCE; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 84879300737     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000353325     Document Type: Article

References (15)

1. KDIGO clinical practice guideline for anemia in chronic kidney disease. Summary of recommendations statements. Kidney International Supplements 2012;2:283-287
2. Department of Health Renal Team National Service Framework for Renal Services: Part One-Dialysis and transplantation, 2004, Department of Health: London
3. Renal Association. Treatment of adults and children with renal failure: standards and audit measures. 3rd Edition., 2002, Royal College of Physicians of London and the Renal Association: London
4. Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant 2004;19:ii1-ii47
5. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. American journal of kidney diseases, 2001. 37(1): p. S182-S238
6. National Collaborating Centre for Chronic Conditions. Anaemia management in chronic kidney disease: national clinical guideline for management in adults and children, 2006, Royal College of Physicians: London
7. Renal Association Clinical Practice Guidelines, 4th Edition. 2007 [cited 2008 15/9/2008]; 4th: [Available from: http://www.renal.org/pages/pages/ clinical-affairs/guidelines.php]
8. Renal Association Clinical Practice Guidelines Committee: Haemodialysis, 5th Edition. 2009. http://www.renal.org/clinical/guidelinessection/ haemodialysis.aspx
9. National Institute for Health and Clinical Excellence (NICE). Anaemia management in people with chronic kidney disease (CG114), 2011
10. http//:www.kdigo.org
11. Movilli, E., et al., Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. American journal of kidney diseases: the official journal of the National Kidney Foundation, 2002. 39(4): p. 850-853
12. Kalantar-Zadeh, K., et al., Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. American Journal of Kidney Diseases, 1995. 26(2): p. 292-299
13. Singh, A.K., et al., Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease. New England Journal of Medicine, 2006. 355(20): p. 2085-2098
14. Drüeke, T.B., et al., Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia. New England Journal of Medicine, 2006. 355(20): p. 2071-2084
15. Pfeffer, M.A., et al., A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. New England Journal of Medicine, 2009. 361(21): p. 2019-2032